Oragenics Inc. (OGEN)
Oragenics Signs Letter of Intent to LicenseCardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Oragenics Signs Letter of Intent to LicenseCardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
Greenland Mines Reports Up To 45% - 55% Increase in Palladium Equivalent (PdEq) Grades at Skaergaard in Sensitivity Study
Devon Energy and Coterra Energy Complete Merger
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
MARA Announces Launch of Consent Solicitation for the 8.750% Senior Secured Notes due 2032 of Long Ridge Energy LLC
GATX Corporation Reports 2026 First-Quarter Results
UAE Regulator And Archer Move To Streamlined Approach for Certifying Midnight in the UAE
Capital Clean Energy Carriers Corp. Announces First Quarter 2026 Financial Results